Clinical Research Site

Redlands, California 92374

4 studies enrolling now · 12 studies all time

What they study most

Depression, Fibromyalgia, Major Depressive Disorder, Major Depressive Disorder With Excessive Daytime Sleepiness Symptoms, Migraine, Treatment Resistant Depression, Uveitis

Studies at this site

• Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design — Recruiting now
• Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol — Recruiting now
• A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms — Recruiting now
• Open-Label Safety Study of AXS-14 in Subjects With Fibromyalgia — Enrolling by invitation
• Initiating Early Control of Migraine Pain and Associated Symptoms — Completed
• Open-Label Safety Study of AXS-05 in Subjects With TRD (EVOLVE) — Stopped early
• Progressing TAAR-1, Dopamine, and Norepinephrine in Depression Using Solriamfetol — Completed
• Phase 2b Pivotal Study of Izokibep in Non-infectious, Intermediate-, Posterior- or Pan-uveitis — Stopped early
• Maximizing Outcomes in Treating Acute Migraine — Completed
• Open-Label Safety Study of AXS-05 in Subjects With Depression — Completed
• A Trial of AXS-05 in Patients With Major Depressive Disorder — Completed
• Mechanistic Evaluation of Response in TRD (MERIT) — Completed